GRAPPA 2020 年会皮肤研究工作组报告。

Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting.

机构信息

L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

A. Kohn, BS, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.

出版信息

J Rheumatol Suppl. 2021 Jun;97:10-16. doi: 10.3899/jrheum.201668.

DOI:10.3899/jrheum.201668

PMID:34074659

Abstract

At the 2020 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Dermatology Outcome Measures (IDEOM) Initiative Psoriasis (PsO) Working Group presented an update on its work to agree on meaningful, valid, and feasible outcome measures for PsO randomized controlled trials and longitudinal observational studies. The Treatment Satisfaction Working Group presented the development of a treatment satisfaction instrument to be utilized in PsO clinical trials. The Musculoskeletal Symptoms Working Group presented an overview of their work conducted to date to define how to best measure musculoskeletal symptoms in PsO clinical studies, and discussed next steps during an open-panel discussion, which included PsO and psoriatic arthritis experts.

摘要

在 2020 年银屑病和银屑病关节炎研究与评估团体（GRAPPA）年会上，国际皮肤病学结局测量（IDEOM）倡议银屑病（PsO）工作组介绍了其在为银屑病随机对照试验和纵向观察研究达成有意义、有效和可行的结局测量方面的工作进展。治疗满意度工作组介绍了用于银屑病临床试验的治疗满意度工具的开发情况。肌肉骨骼症状工作组介绍了迄今为止为确定如何在银屑病临床研究中最好地测量肌肉骨骼症状而开展的工作概述，并在包括银屑病和银屑病关节炎专家在内的公开小组讨论中讨论了下一步措施。